Valkyrie Clinical Trials(Additional Suite) — Los Angeles, California

Valkyrie Clinical Trials(Additional Suite) is a clinical research site located in Los Angeles, California, United States 90067.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

Valkyrie Clinical Trials(Additional Suite) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Carcinoma, Non-Small-Cell Lung, Ovarian Neoplasms, Endometrial Neoplasms.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer.

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Valkyrie Clinical Trials(Additional Suite)?

Valkyrie Clinical Trials(Additional Suite) has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Valkyrie Clinical Trials(Additional Suite) conducted?

Valkyrie Clinical Trials(Additional Suite) has 1 clinical trials on record, with 1 currently active. Their work covers Carcinoma, Non-Small-Cell Lung, Ovarian Neoplasms, Endometrial Neoplasms.

Is Valkyrie Clinical Trials(Additional Suite) accredited by Crixeo Health?

Valkyrie Clinical Trials(Additional Suite) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Valkyrie Clinical Trials(Additional Suite)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.